Moneycontrol
HomeHealth & FitnessWeight loss drug Ozempic launch in India: Is it safe for diabetes patients? Does it control blood sugar?
Trending Topics

Weight loss drug Ozempic launch in India: Is it safe for diabetes patients? Does it control blood sugar?

Novo Nordisk’s weekly injection for type 2 diabetes, Ozempic, is set to launch in India. Here’s how it works, its benefits, risks, and impact on weight loss.

October 02, 2025 / 11:55 IST
Story continues below Advertisement
Ozempic, a once-weekly injection, regulates blood sugar and aids weight loss in type 2 diabetes patients. (Image: AFP)

Ozempic has caught the eye of people worldwide for its ability to help with weight loss. The drug, which goes by the generic name semaglutide, is a shot you take once a week and has been approved by the Central Drugs Standard Control Organisation (CDSCO). This medication is set to enter the Indian market and play a big role for patients who want to keep their blood sugar in check and also aim to reach a healthier weight.

What exactly is Ozempic?

Story continues below Advertisement

Ozempic (semaglutide) is a drug utilized to assist people with type 2 diabetes to maintain their blood sugar levels evenly. It maintains glucose levels throughout the day by improving the body’s insulin response. Improving blood glucose levels is only one function of Ozempic. It has also gained global popularity as a weight loss aid, especially for people who are overweight or obese. Another benefit of this diabetes drug is the ease of adherence to treatment regimens as it comes as a weekly injection in comparison to the daily medications that are required for other diabetes medications.

Also Read: Ozempic weight loss might cost you muscle strength, says new study